Rachel J M Abbott Selected Research

glycyl- leucyl- cysteinyl- threonyl- leucyl- valyl- alanyl- methionyl- leucine

9/2009

Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachel J M Abbott Research Topics

Disease

3	Epstein-Barr Virus Infections 12/2013 - 09/2009
3	Infectious Mononucleosis (Glandular Fever) 12/2013 - 09/2009
2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
1	Synovial Sarcoma (Synovioma) 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Persistent Infection 12/2013

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 01/2023 - 09/2009
3	Peptides (Polypeptides)IBA 01/2022 - 05/2013
2	HLA-A Antigens (HLA-A)IBA 01/2022 - 09/2009
2	EpitopesIBA 05/2013 - 09/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	CytokinesIBA 01/2023
1	ChemokinesIBA 01/2023
1	CD40 Ligand (CD40L)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 05/2013
1	glycyl- leucyl- cysteinyl- threonyl- leucyl- valyl- alanyl- methionyl- leucineIBA 09/2009
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 09/2009

Therapy/Procedure

1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Therapeutics 01/2022